Blastocystis: To treat or not to treat..

Clinical Infectious Diseases

Volumn 54, Issue 1, 2012, Pages 105-110

  Coyle, Christina M ^a,c   Varughese, Julie ^a   Weiss, Louis M ^a,b   Tanowitz, Herbert B ^a,b,c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b Department of Pathology   (United States)

^c JACOBI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CLIOQUINOL; DIIODOHYDROXYQUIN; EMETINE; FURAZOLIDONE; GARLIC EXTRACT; HERBACEOUS AGENT; KETOCONAZOLE; METRONIDAZOLE; NITAZOXANIDE; PAROMOMYCIN; PENTAMIDINE; PLACEBO; PROBIOTIC AGENT; SACCHAROMYCES BOULARDII EXTRACT; SULFAMETHOXAZOLE; TINIDAZOLE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ARTICLE; BLASTOCYSTIS; BLASTOCYSTOSIS; CLINICAL FEATURE; CONCENTRATION RESPONSE; CYST; DISEASE SEVERITY; DRUG EFFICACY; FECES ANALYSIS; FOLLOW UP; GASTROINTESTINAL SYMPTOM; HUMAN; IRRITABLE COLON; NONHUMAN; PARASITE SERODIAGNOSIS; PATHOGENICITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN DISEASE; TAXONOMY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ANIMALS; ANTIPROTOZOAL AGENTS; ASYMPTOMATIC DISEASES; BLASTOCYSTIS; BLASTOCYSTIS INFECTIONS; DISEASE MODELS, ANIMAL; HUMANS;

EID: 84555170735     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cir810     Document Type: Article

References (59)

1. Stensvold CR, Arendrup MC, Jespersgaard C, Molbak K, Nielsen HV. Detecting Blastocystis using parasitologic and DNA-based methods: a comparative study. Diagn Microbiol Infect Dis 2007; 59:303-7. (Pubitemid 350016702)
2. Tan KS, Mirza H, Teo JD, Wu B, Macary PA. Current views on the clinical relevance of Blastocystis spp. Curr Infect Dis Rep 2010; 12:28-35.
3. Tan KS. New insights on classification, identification, and clinical relevance of Blastocystis spp. Clin Microbiol Rev 2008; 21:639-65.
4. Zierdt CH. Blastocystis hominis-past and future. Clin Microbiol Rev 1991; 4:61-79.
5. Silberman JD, Sogin ML, Leipe DD, Clark CG. Human parasite finds taxonomic home. Nature 1996; 380:398. (Pubitemid 26102715)
6. Arisue N, Hashimoto T, Yoshikawa H, et al. Phylogenetic position of Blastocystis hominis and of stramenopiles inferred from multiple molecular sequence data. J Eukaryot Microbiol 2002; 49:42-53. (Pubitemid 34231468)
7. Patterson DJ. The evolution of protozoa. Mem Inst Oswaldo Cruz 1988; 83(Suppl 1):580-600.
8. Noel C, Peyronnet C, Gerbod D, et al. Phylogenetic analysis of Blastocystis isolates from different hosts based on the comparison of smallsubunit rRNA gene sequences.Mol BiochemParasitol 2003; 126:119-23. (Pubitemid 36120612)
9. Santin M, Gomez-Munoz MT, Solano-Aguilar G, Fayer R. Development of a new PCR protocol to detect and subtype Blastocystis spp. from humans and animals. Parasitol Res 2011; 109:205-12.
10. Stensvold CR, Alfellani MA, Norskov-Lauritsen S, et al. Subtype distribution of Blastocystis isolates from synanthropic and zoo animals and identification of a new subtype. Int J Parasitol 2009; 39:473-9.
11. Yoshikawa H, Wu Z, Kimata I, et al. Polymerase chain reaction-based genotype classification among human Blastocystis hominis populations isolated from different countries. Parasitol Res 2004; 92:22-9. (Pubitemid 38167933)
12. Kurniawan A, Karyadi T, Dwintasari SW, et al. Intestinal parasitic infections in HIV/AIDS patients presenting with diarrhoea in Jakarta, Indonesia. Trans R Soc Trop Med Hyg 2009; 103:892-8.
13. Tasova Y, Sahin B, Koltas S, Paydas S. Clinical significance and frequency of Blastocystis hominis in Turkish patients with hematological malignancy. Acta Med Okayama 2000; 54:133-6.
14. Londono AL, Mejia S, Gomez-Marin JE. [Prevalence and risk factors associated with intestinal parasitism in preschool children from the urban area of Calarca, Colombia]. Rev Salud Publica (Bogota) 2009; 11:72-81.
15. Taylor DN,Houston R, ShlimDR, Bhaibulaya M, Ungar BL, Echeverria P. Etiology of diarrhea among travelers and foreign residents in Nepal. JAMA 1988; 260:1245-8.
16. Babcock D, Houston R, Kumaki D, Shlim D. Blastocystis hominis in Kathmandu, Nepal. N Engl J Med 1985; 313:1419. (Pubitemid 16211852)
17. Keystone JS. Blastocystis hominis and traveler's diarrhea. Clin Infect Dis 1995; 21:102-3.
18. UdkowMP, Markell EK. Blastocystis hominis: prevalence in asymptomatic versus symptomatic hosts. J Infect Dis 1993; 168:242-4. (Pubitemid 23178760)
19. Grossman I, Weiss LM, Simon D, Tanowitz HB, Wittner M. Blastocystis hominis in hospital employees. Am J Gastroenterol 1992; 87:729-32.
20. Shlim DR, Hoge CW, Rajah R, Rabold JG, Echeverria P. Is Blastocystis hominis a cause of diarrhea in travelers? A prospective controlled study in Nepal. Clin Infect Dis 1995; 21:97-101.
21. Clark CG. Extensive genetic diversity in Blastocystis hominis. Mol Biochem Parasitol 1997; 87:79-83. (Pubitemid 27293336)
22. Stensvold CR, Nielsen HV, Molbak K, Smith HV. Pursuing the clinical significance of Blastocystis-diagnostic limitations. Trends Parasitol 2009; 25:23-9.
23. Abou GamraMM, Elwakil HS, El Deeb HK, Khalifa KE, Abd Elhafiz HE. The potential use of 29 kDa protein as a marker of pathogenicity and diagnosis of symptomatic infections with Blastocystis hominis. Parasitol Res 2011; 108:1139-46.
24. Abdel-Hameed DM, Hassanin OM. Protease activity of Blastocystis hominis subtype3 in symptomatic and asymptomatic patients. Parasitol Res 2011; 109:321-7.
25. Elwakil HS, Hewedi IH. Pathogenic potential of Blastocystis hominis in laboratory mice. Parasitol Res 2010; 107:685-9.
26. Stensvold CR, Lewis HC, Hammerum AM, et al. Blastocystis: unravelling potential risk factors and clinical significance of a common but neglected parasite. Epidemiol Infect 2009; 137:1655-63.
27. Dominguez-Marquez MV, Guna R, Munoz C, Gomez-Munoz MT, Borras R. High prevalence of subtype 4 among isolates of Blastocystis hominis from symptomatic patients of a health district of Valencia (Spain). Parasitol Res 2009; 105:949-55.
28. Eroglu F, Genc A, Elgun G, Koltas IS. Identification of Blastocystis hominis isolates from asymptomatic and symptomatic patients by PCR. Parasitol Res 2009; 105:1589-92.
29. Yakoob J, JafriW, BegMA, et al. Irritable bowel syndrome: is it associated with genotypes of Blastocystis hominis. Parasitol Res 2010; 106:1033-8.
30. Zuel-Fakkar NM, AbdelHameed DM,Hassanin OM. Study of Blastocystis hominis isolates in urticaria: a case-control study. Clin Exp Dermatol 2011. doi: 10.1111/j.1365-2230.2011.04127.
31. HameedDM,HassaninOM, Zuel-Fakkar NM. Association of Blastocystis hominis genetic subtypes with urticaria. Parasitol Res 2011; 108:553-60.
32. Suresh K, Smith H. Comparison of methods for detecting Blastocystis hominis. Eur J Clin Microbiol Infect Dis 2004; 23:509-11. (Pubitemid 38901341)
33. Hu KC, Lin CC, Wang TE, Liu CY, Chen MJ, Chang WH. Amoebic liver abscess or is iti Gut 2008; 57:627, 683.
34. Patino WD, Cavuoti D, Banerjee SK, Swartz K, Ashfaq R, Gokaslan T. Cytologic diagnosis of Blastocystis hominis in peritoneal fluid: a case report. Acta Cytol 2008; 52:718-20.
35. Yakoob J, JafriW, Jafri N, et al. Irritable bowel syndrome: in search of an etiology: role of Blastocystis hominis. AmJTropMedHyg 2004; 70:383-5. (Pubitemid 38525549)
36. Chen TL, Chan CC, Chen HP, et al. Clinical characteristics and endoscopic findings associated with Blastocystis hominis in healthy adults. Am J Trop Med Hyg 2003; 69:213-16.
37. Valsecchi R, Leghissa P, Greco V. Cutaneous lesions in Blastocystis hominis infection. Acta Derm Venereol 2004; 84:322-3. (Pubitemid 38943526)
38. Kick G, Rueff F, Przybilla B. Palmoplantar pruritus subsiding after Blastocystis hominis eradication. Acta Derm Venereol 2002; 82:60. (Pubitemid 34450550)
39. Katsarou-Katsari A, Vassalos CM, Tzanetou K, Spanakos G, Papadopoulou C, Vakalis N. Acute urticaria associated with amoeboid forms of Blastocystis sp. subtype 3. Acta Derm Venereol 2008; 88:80-1. (Pubitemid 351212150)
40. Brandt LJ, Bjorkman D, Fennerty MB, et al. Systematic review on the management of irritable bowel syndrome in North America. Am J Gastroenterol 2002; 97:S7-26.
41. Boorom KF, Smith H, Nimri L, et al. Oh my aching gut: irritable bowel syndrome, Blastocystis, and asymptomatic infection. Parasit Vectors 2008; 1:40.
42. Giacometti A, Cirioni O, Fiorentini A, Fortuna M, Scalise G. Irritable bowel syndrome in patients with Blastocystis hominis infection. Eur J Clin Microbiol Infect Dis 1999; 18:436-9. (Pubitemid 29531210)
43. Yakoob J, Jafri W, Beg MA, et al. Blastocystis hominis and Dientamoeba fragilis in patients fulfilling irritable bowel syndrome criteria. Parasitol Res 2010; 107:679-84.
44. Tungtrongchitr A, Manatsathit S, Kositchaiwat C, et al. Blastocystis hominis infection in irritable bowel syndrome patients. Southeast Asian J Trop Med Public Health 2004; 35:705-10. (Pubitemid 39486446)
45. Stark D, van Hal S, Marriott D, Ellis J, Harkness J. Irritable bowel syndrome: a review on the role of intestinal protozoa and the importance of their detection and diagnosis. Int J Parasitol 2007; 37: 11-20. (Pubitemid 44958562)
46. Liebregts T, Adam B, Bredack C, et al. Immune activation in patients with irritable bowel syndrome. Gastroenterology 2007; 132: 913-20. (Pubitemid 46440872)
47. Ohlsson B, Sjoberg K, Alm R, Fredrikson GN. Patients with irritable bowel syndrome and dysmotility express antibodies against gonadotropinreleasing hormone in serum. Neurogastroenterol Motil 2011. 23: 1000-e459. doi 10.1111/j.1365-2982.2011June 30.
48. Hussain R, Jaferi W, Zuberi S, et al. Significantly increased IgG2 subclass antibody levels to Blastocystis hominis in patients with irritable bowel syndrome. Am J Trop Med Hyg 1997; 56:301-6. (Pubitemid 27181016)
49. Kukoschke KG, Necker A, Müller HE. Detection of Blastocystis hominis by direct microscopy and culture. Eur J Clin Microbiol Infect Dis 1990; 9:305-7. (Pubitemid 20157341)
50. Zman V, Khan KZ. A comparison of direct microscopy with culture for the diagnosis of Blastocystis hominis. Southeast Asian J Trop Med Public Health 1994; 25:792-3.
51. Zierdt CH, Nagy B. Antibody response to Blastocystis hominis. Ann Int Med 1993; 118:985-6.
52. Markell EK, Udkow MP. Blastocystis hominis: pathogen or fellow traveler? Am J Trop Med Hyg 1986; 35:1023-6. (Pubitemid 17172955)
53. Stensvold CR, Smith HV, Nagel R, Olsen KE, Traub RJ. Eradication of Blastocystis carriage with antimicrobials: reality or delusion? J Clin Gastroenterol 2010; 44:85-90.
54. Nigro L, Larocca L, Massarelli L, et al. A placebo-controlled treatment trial of Blastocystis hominis infection with metronidazole. J Travel Med 2003; 10:128-30. (Pubitemid 36383946)
55. Moghaddam DD, Ghadirian E, Azami M. Blastocystis hominis and the evaluation of efficacy of metronidazole and trimethoprim/sulfamethoxazole. Parasitol Res 2005; 96:273-5. (Pubitemid 40933676)
56. Ok UZ, Girginkardesler N, Balcioglu C, Ertan P, Pirildar T, Kilimcioglu AA. Effect of trimethoprim-sulfamethaxazole in Blastocystis hominis infection. Am J Gastroenterol 1999; 94:3245-7.
57. Sohail MR, Fischer PR. Blastocystis hominis and travelers. Travel Med Infect Dis 2005; 3:33-8. (Pubitemid 40028828)
58. Yakoob J, Abbas Z, Beg MA, et al. In vitro sensitivity of Blastocystis hominis to garlic, ginger, white cumin, and black pepper used in diet. Parasitol Res 2011; 109:379-85.
59. Dinleyici EC, ErenM, Dogan N, Reyhanioglu S, Yargic ZA, Vandenplas Y. Clinical efficacy of Saccharomyces boulardii or metronidazole in symptomatic children with Blastocystis hominis infection. Parasitol Res 2011; 108:541-5.